Plexpress Release: New Whitepaper Compares Gene Expression Analysis Technologies
Choice of gene expression analysis technologies are dependent on specific study needs and, with the many genome-wide and targeted options available, deciding on the best approach can be challenging. This is especially so when trying to find the right balance between multiplex analysis (number of genes) and project depth (number of samples). In the last ten years new technologies have emerged such as Plexpress’ TRAC (Transcript Analysis with aid of Affinity Capture) which successfully combines high sample throughput with efficient gene multiplexing. Integration of the TRAC platform with other services such as microarrays or pre-validated gene panels for ADME-Tox applications also provides time-and-cost effective flexibility for a range of studies.
The whitepaper aims to simplify the reader’s choice of gene expression analysis by providing detailed information on each method’s applications, strengths and weaknesses. Clear comparisons are offered, reflecting upon important cost and efficiency considerations, providing researchers with the insight to identify the best method for the task at hand.
To see these comparisons and to learn more about gene expression analysis methods download the whitepaper. For more information about TRAC and Plexpress, please visit www.plexpress.com
Editors’ notes About Plexpress Plexpress was established as a spinoff from the Finnish Technology Research Center VTT in 2007. Including R&D at VTT, the company’s TRAC technology has been developed continuously for nearly 10 years and it has been documented in over 15 publications. The technology was originally developed for demanding bioprocess applications, which required a very robust solution for gene expression analysis. Since starting operations in 2008, the company has carried out over 50 projects using the TRAC technology in the fields of pharmaceutical development and academic research. For further information see: www.plexpress.com